Discover 2,221 paid clinical trials in Hayward, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,221
Acupuncture for the Treatment of Chronic Post-Chemotherapy Fatigue
for
Fatigue
Location: Berkeley CA
Sponsor: Alta Bates Summit Medical Center
Sex: All
Age: 18 - 64
Code: NCT00658034
Phase 3, Recruiting
Platelet Rich Plasma Testis Treatment for Infertile Men
for
Male Infertility, Nonobstructive Azoospermia, Azoospermia
Location: Stanford CA
Sponsor: Stanford University
Sex: Male
Age: 18+
Code: NCT05479474
Recruiting
Study of an Intrathecal Port and Catheter System for Subjects With Spinal Muscular Atrophy
Location: Palo Alto CA, Orange CA, San Diego CA, Phoenix AZ,
Sponsor: Alcyone Therapeutics, Inc
Sex: All
Age: 3+
Code: NCT05866419
Recruiting
A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With REGN5678 for Adult Participants With Advanced Prostate Cancer
for
Metastatic Castration-resistant Prostate Cancer
Location: Palo Alto CA, Houston TX, Milwaukee WI, Louisville KY,
Sponsor: Regeneron Pharmaceuticals
Sex: Male
Age: 18+
Code: NCT05125016
Phase 1, Phase 2, Recruiting
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
for
Breast Cancer
Location: Palo Alto CA, San Francisco CA, Santa Monica CA,
Sponsor: Greenwich LifeSciences, Inc.
Sex: All
Age: 18 - 70+
Code: NCT05232916
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
for
Ovarian Neoplasms, Fallopian Tube Neoplasms,
Location: Palo Alto CA, Reno NV, Santa Barbara CA, Burbank CA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07213804
Phase 3, Recruiting
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
for
Breast Neoplasms
Location: Palo Alto CA, Sacramento CA, Santa Barbara CA,
Sponsor: BioNTech SE
Sex: All
Age: 18+
Code: NCT07173751
Phase 3, Recruiting
A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias
for
High-risk Myelodysplastic Syndrome,
Location: Palo Alto CA, Duarte CA, Houston TX, St Louis MO,
Sponsor: Crossbow Therapeutics, Inc.
Sex: All
Age: 12+
Code: NCT06994676
Phase 1, Recruiting
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
for
Solid Tumor
Location: Palo Alto CA, Chicago IL, Augusta GA, Tampa FL,
Sponsor: Eisai Inc.
Sex: All
Age: 18+
Code: NCT04300556
Phase 1, Phase 2, Recruiting
Onyx™ Liquid Embolic IDE Clinical Study
for
Peripheral Arterial Hemorrhage, Trauma, GI Bleed, Ulcer,
Location: Palo Alto CA, Los Angeles CA, Irvine CA, Phoenix AZ,
Sponsor: Medtronic Endovascular
Sex: All
Age: 22+
Code: NCT06742801
Recruiting
Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma
for
Advanced Or Metastatic Merkel Cell Carcinoma
Location: Stanford CA, San Francisco CA, Los Angeles CA,
Sponsor: TuHURA Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT06947928
Phase 2, Phase 3, Recruiting
A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)
for
Lupus Nephritis, Primary Membranous Nephropathy
Location: Ann Arbor MI, Stony Brook NY, Tustin CA, Dallas TX,
Sponsor: Nkarta, Inc.
Sex: All
Age: 18 - 70+
Code: NCT06557265
Phase 1, Phase 2, Recruiting
A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)